KKR buys HealthCare Royalty Partners as firm deepens bet on life sciencesnews2025-07-30T14:39:38+00:00July 30th, 2025|Endpoints News|
How CEO Stephen Hemsley plans to turn around a struggling UnitedHealthnews2025-07-30T14:02:09+00:00July 30th, 2025|Endpoints News|
Cardiff’s targeted therapy shows early promise in KRAS-mutated colorectal cancersnews2025-07-30T13:13:58+00:00July 30th, 2025|Endpoints News|
GSK reaffirms goal of bringing Blenrep to US, reports fail with TIM-3 inhibitornews2025-07-30T11:35:50+00:00July 30th, 2025|Endpoints News|
Madrigal licenses preclinical GLP-1 from CSPC for $120M upfrontnews2025-07-30T11:01:25+00:00July 30th, 2025|Endpoints News|
Viridian inks Japan licensing deal as it seeks to rival Amgen’s Tepezzanews2025-07-30T08:00:56+00:00July 30th, 2025|Endpoints News|
Vinay Prasad out at FDA after agency backtracks on Sarepta decisionnews2025-07-30T00:54:09+00:00July 30th, 2025|Endpoints News|
Senate confirms Susan Monarez to lead CDC for Trump administrationnews2025-07-29T22:28:26+00:00July 29th, 2025|Endpoints News|
The AI upcoding and denial wars have arrivednews2025-07-29T16:17:22+00:00July 29th, 2025|Endpoints News|
